Latest market price
248.98
-2.29-0.91%
OverviewShort InterestFilings
ASNDQT65Ascendis Pharma A/S·NASDAQ
248.98-0.91%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 26, 20266-KForeign issuer report
Oct 16, 20266-KForeign issuer report
Oct 14, 20266-KForeign issuer report
Sep 29, 20266-KForeign issuer report
Sep 28, 20264Statement of changes in beneficial ownership
Sep 15, 20266-KForeign issuer report
Sep 15, 20266-KForeign issuer report
Sep 09, 20264Statement of changes in beneficial ownership
Sep 09, 20266-KForeign issuer report
Sep 09, 20266-KForeign issuer report
Sep 03, 20264Statement of changes in beneficial ownership
Aug 31, 20266-KForeign issuer report
Aug 18, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 20266-KForeign issuer report
Aug 13, 20266-KForeign issuer report
Aug 12, 20266-KForeign issuer report
Aug 06, 20266-KForeign issuer report
Jul 15, 20266-KForeign issuer report
Jun 30, 20266-KForeign issuer report
Jun 29, 20266-KForeign issuer report
Jun 17, 20266-KForeign issuer report
Jun 15, 20266-KForeign issuer report
Jun 12, 20266-KForeign issuer report
Jun 10, 20266-KForeign issuer report
#1 / 25 of 334
Page
▼
/ 14